bovine embryo at 16-cell stage can synthesize interferon-tau (IFNT), which regulates local immune environment in the oviduct in vitro. 4 This finding indicates that the bovine embryo starts to produce IFNT before entering into the uterus from the oviduct. In addition, we have shown in vitro that the bovine embryo from morula (Day-5) to blastocyst stage (Day-9) starts to communicate with uterine epithelial and immune cells and generates a "local" anti-inflammatory response in the uterus, which is mediated in part by IFNT. 5 In a further study, using a superovulation and artificial insemination model (superovulation/AI model), our laboratory has shown in vivo evidence that Day-7 embryo secretes IFNT in the uterus that induces an anti-inflammatory immune response in local immune cells of the uterus in cows. 6 The findings above indicate that an immunological crosstalk between the embryo and immune cells exists locally in the uterus at Day-7 of pregnancy in cows, which is regulated by IFNT from the embryos. However, response of peripheral blood immune cells to the presence of early embryo in the uterus is still unclear at Day-7 of pregnancy in cows.
Interferon-tau, a type I interferon, is responsible for the process of maternal recognition of pregnancy in ruminants. 7, 8 It is produced from trophectoderm of the bovine embryo and secreted into the uterus, in which it activates interferon-stimulated genes (ISGs) as early as at Day-7 of pregnancy in cows. 9 Interestingly, expression of ISGs has also been found in extra-uterine tissues such as in corpus luteum 10 and in peripheral blood immune cells [11] [12] [13] [14] 
| MATERIAL S AND ME THODS

| Ethics statement
Animal experiments were conducted in accordance with the Guiding 
| Experimental design
In total, 19 Japanese Black cows were brought into a superovulation program using different hormonal treatments. At 12-18 hours postestrus (Day-0 = estrus), cows were either inseminated (n = 13) or remained without inseminations (control group, n = 6). Blood samples were collected twice from each cow. The first blood sample was collected immediately after artificial insemination (AI), considered as Day-1. The blood sampling was also done just after uterine flushing (Day-7) corresponding to the presence of compact morulae or blastocysts in the uterus. The blood samples were immediately transported to the laboratory at 4-8°C in an icebox. In the labora- to confirm the number and stage of recovered embryos. The number (mean ± SEM) of recovered embryos per cow was 9.6 ± 1.4.
| Isolation of PMNs and PBMCs
PMNs and PBMCs were isolated as a previously described pro- 
| RNA extraction and cDNA synthesis
Total RNA was extracted from PMNs and PBMCs using TRIzol reagent as previously described. 16 The RNA extracted from all samples was detected by ultraviolet (UV) spectroscopy (optical density, 260 nm), and the concentration was measured using a spectrophotometer (Eppendorf, Munich, Germany) at 260 and 280 nm absorbance values. The total extracted RNA was stored in RNA storage solution (Ambion, Austin, TX, USA) at −80°C until cDNA conversion.
The cDNA synthesis was carried out according to a previously described protocol. 5 The synthesized cDNA was stored at −30°C.
| Real-time PCR
Quantitative real-time PCR of target genes (Table 1) 
| EIA for determination of P4 concentration in blood plasma
Plasma P4 concentration was determined using EIA after diethyl ether extraction as previously described, 18 and the extraction efficiency was 90%. The standard curve ranged from 0.05 to 50 ng ⁄mL, and the 50% effective dose (ED50) of the assay was 3.1 ng ⁄mL. The intra-and inter-assay coefficients of variation (CVs) averaged 7.4% and 8.7%, respectively.
| Statistical analysis
Data are presented as mean ± SEM. Statistical analysis was performed using SPSS software version 14.0 (SPSS Inc, Chicago, IL, USA). Student's t test was used to compare the data between two groups. P values <0.05 were considered to be statistically significant.
| RE SULTS
| Gene expression in circulating PMNs was influenced by the presence of Day-7 embryos in the uterus
In order to detect the response of peripheral blood PMNs by the presence of multiple Day-7 embryos in the uterus, gene expression 
| Progesterone (P4) concentration in blood plasma was not altered in inseminated cows when compared to non-inseminated cows
Plasma P4 concentrations were measured by EIA for investigation of possible effect of P4 on regulation of immune cells gene expressions.
Plasma P4 concentrations were significantly increased (P < 0.01) at
F I G U R E 1 Relative mRNA expression of IFNT-stimulated genes (ISG15 and OAS1), enzyme related to PGE2 synthesis (PTGES), proinflammatory cytokines (TNFA and IL1B), anti-inflammatory cytokines (TGFB1 and IL10), and immune tolerance factor (Foxp3) in PMNs.
Different small letters (a,b) above black bars denote significant difference at P < 0.05. Asterisks (* P < 0.05, ** P < 0.01) denote significant differences between gray (non-inseminated) and black (inseminated) bars at Day-7. Values are presented as mean ± SEM of 6 noninseminated (non-AI) and 13 inseminated (AI) cows Day-7 in both inseminated and non-inseminated cows, when compared to that at Day-1 ( Figure 3A) . However, no significant difference was observed in plasma P4 level between inseminated and non-inseminated cows ( Figure 3A ). Corpus luteum (CL) numbers were also not significantly differed between inseminated and noninseminated cows ( Figure 3B ).
F I G U R E 2 Relative mRNA expression of IFNT-stimulated genes (ISG15 and OAS1), enzyme related to PGE2 synthesis (PTGES), proinflammatory cytokines (TNFA and IL1B), anti-inflammatory cytokines (TGFB1 and IL10), and immune tolerance factor (Foxp3) in PBMCs.
Different small letters (a,b) above black bars denote significant difference at P < 0.05. Asterisks (*P < 0.05, **P < 0.01) denote significant differences between gray (non-inseminated) and black (inseminated) bars at Day-7. Values are presented as mean ± SEM of 6 noninseminated (non-AI) and 13 inseminated (AI) cows Interferon-tau is known as an immunosuppressive cytokine, which has anti-proliferative action on lymphocytes. 21 In a recent study, we provide in vivo evidence that Day-7 embryo secretes IFNT in the uterus in cows following superovulation and artificial insemination. 6 In the present study, we evaluated gene expression of peripheral blood immune cells at Day-7 of post-inseminations in the same superovulated cows used in our previous study 6 and found that ISGs were up-regulated in both circulating PMNs and PBMCs, suggesting that the circulating immune cells somehow recognize the existence of IFNT in the uterus secreted by Day-7 embryos (compact morulae and blastocysts). In consistent with our results, activation of ISGs was also found in peripheral blood leukocytes on Day-8 12 and Day-12 13, 22 of early pregnancy in cows. These findings from ours and others have raised the question how peripheral blood immune cells can recognize IFNT, which is secreted in the uterus locally by the embryos. There is evidence that IFNT enters into the blood via uterine vein. [23] [24] [25] Thus, a low level of IFNT may pass into the blood from uterine cavity, which may induce ISGs expression in peripheral blood immune cells. There is another possibility that IFNT can reach to the uterine stroma, [26] [27] [28] in which immune cells such as dendritic cells (DCs) and macrophages are present in the uterus in cows. 29 It is reported that DCs from fetalmaternal interface could traffic to the regional lymphnodes. 30 Foxp3 is a key transcription factor that regulates the development and function of CD4+CD25+ regulatory T cells (Treg). 33 Recently, functions of Foxp3 were also reported in other cell types, specifically in epithelial cells of many lineages including the breast 34 and lungs. 35 In our study, Foxp3 expression was activated in peripheral blood PMNs by the presence of Day-7 embryos in the cow uterus.
However, functions of Foxp3 in PMNs have not yet been elucidated.
It is well established that TGFB works synergistically with PGE2 for the development of Treg cells for immune tolerance. 36 Therefore, in the present study, activation of Foxp3 along with up-regulation of TGFB1 and PTGES in PMNs might act synergistically to generate an anti-inflammatory and immune tolerance conditions in the cow.
Similar to our findings, pregnancy has long been reported to be a Th2 (anti-inflammatory) phenomenon, 37 while Th1 (pro-inflammatory) dominance was observed in pregnancy failure. 38 Interestingly, it was demonstrated that IL10 (anti-inflammatory cytokine) plays pivotal role for prevention of fetal loss, and administration of IFNT supports the pregnancy in abortion-prone mouse by promoting IL10 production. 39 In our present study, since interferon-stimulated genes were upregulated with other anti-inflammatory cytokine expressions, IFNT from Day-7 embryo is likely to be involved for modulation of gene expressions of circulating immune cells, which requires further investigation. In the present study, gene expressions levels of immune cells by the embryos were increased by only 1.5-to 2.5-fold, suggesting that IFNT signaling was not activated in whole circulating PMNs and PBMCs.
Therefore, it is possible that only a population of each type of immune cells (PMNs and PBMCs) might be activated, which remains to be investigated.
Progesterone, a pregnancy maintenance hormone, is also known as an immunosuppressive molecule, which has anti-proliferative function on lymphocytes. 40 In our study, there was no difference observed in corpus luteum number and P4 concentration in blood plasma between inseminated and non-inseminated cows. Thus, we can exclude the possibility that regulation of gene expressions in circulating PMNs and PBMCs observed in this study was not mediated by plasma P4.
| CON CLUS ION
Overall, our findings suggest that the presence of multiple embryos in the uterus generates an anti-inflammatory (Th2) immune response in peripheral blood immune cells at Day-7 of pregnancy in cows, which might potentially show the regulation of mother immunity to accept semi-allogenic embryo in the uterus via an IFNTdependent mechanism. Further study is needed to identify the molecular mechanisms by which Day-7 embryo in the uterus communicates with peripheral blood immune cells for generation of an anti-inflammatory immune response to achieve maternal tolerance. 
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